Wedbush Morgan Downgrades The Medicines Company (MDCO) to Underperform
Wedbush Morgan downgrades The Medicines Company (Nasdaq: MDCO) from Neutral to Underperform.
Wedbush analyst says, "We do not expect recently acquired ...
Wedbush Morgan Upgrades Medicines Co. (MDCO) To Buy, Says Sell-Off Overdone
Wedbush Morgan issued a mid-day upgrade, from Hold to Buy, on Medicines Co. (Nasdaq: MDCO), which is down over 30% after Cangrelor failed the Phase 3 program for percutaneous coronary ...
